News

GlobalData on MSN3d
Firefly Neuroscience acquires Evoke Neuroscience to expand commercial footprint
The terms of the purchase agreement include a $6m transaction, split evenly between cash and Firefly common stock priced at ...
Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.
Builds upon Firefly’s recent acceptance into the NVIDIA Connect program Marks next major step toward building a proprietary foundation model of the human brain KENMORE, N.Y., May 05, 2025 (GLOBE ...
Nasdaq4d
Firefly Neuroscience Issues Correction on Acquisition Announcement of Evoke Neuroscience, Inc.
Firefly's acquisition of Evoke Neuroscience significantly expands its proprietary database to over 180,000 standardized EEG/ERP assessment records, enhancing its research capabilities. The ...
Morningstar5d
Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.
Marks next major step toward building a proprietary foundation model of the human brain KENMORE, N.Y., May 05, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” or the “Company ...
manilatimes5d
Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.
Marks next major step toward building a proprietary foundation model of the human brain KENMORE, N.Y., May 05, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly,” or the "Company”) (NASDAQ ...
Seeking Alpha4d
Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.
Purchase terms include: $6 million, to be paid 50% in cash and 50% in Firefly’s common stock priced at $3.50 per share. Eligibility for Evoke’s investors to receive a $500,000 earn-out to be ...
Investing5d
Firefly Neuroscience acquires Evoke for brain health tech
KENMORE, N.Y. - Firefly Neuroscience, Inc. (NASDAQ: AIFF), a $38 million market cap company known for its Artificial Intelligence (AI) solutions in brain health, has acquired Evoke Neuroscience ...